Post on 22-Mar-2016
description
transcript
1
Explore ››
‘Customer centricity’ is the new mantra »
Enriching the end-to-end customer experience ‘beyond the pill’. In today’s world success comes from engaging with patients at every touch point along their journey – before, during and after treatment initiation.
Patient-centred companies are putting patients at the heart of what they do, through education, service design and adherence programmes. They are identifying where meaningful connections can be made and creating engaging experiences to improve health outcomes.
Engaging with patients at every step of their journey
2
SERVICES & SUPPORT
ED
UC
ATIO
N PRODU
CTS
/ D
RU
GS
MULTIPLE CHANNELS & TOUCHPOINTS PERSONAL
ISED
& TA
RGET
ED
ACCESSIBLE, INNOVATIVE & ONGOING
3
Explore ››
Patient empowerment is key »
Digital is fueling patient participation.Growing access to information means that patients are more informed about their health than ever before. They are seeking more knowledge about diseases and taking more active roles in treatment decisions.
The Internet has made information on every aspect of health transparent and instantly accessible. Patients are increasingly comfortable with game-changing technologies such as new social media platforms and mobile apps.
Technology is expanding where healthcare is practiced; from the traditional setting of the doctor’s office or hospital to wherever the patient happens to be. It allows patients to broadcast attitudes on every aspect of their healthcare experience, as well as connect more easily with each other.
A new social momentum is influencing disease and brand engagement.
information
5
Explore ››
A new imperative to better understand patient behaviour»
It is predicted that the biggest improvements in healthcare outcomes will come from better understanding of behaviour.
‘Behavioural Economic’ theory tells us that our actions are primarily influenced by our subconscious. Behaviour is not always reasoned and rational.
People are influenced hugely by the world around them. They use familiar anchors, short cuts, and ‘rules of thumb’ to make decisions. They are subject to a mass of cognitive biases, such as loss aversion, scarcity bias and the ‘herd’ instinct to follow others.
Boosting patient compliance and ensuring medicines are taken as advised demands a shift in patient behaviour. Increased success will be driven by adopting incentives and services which encourage patients to adopt healthy lifestyles.
Identifying the underlying barriers and levers to behavioural change
6
We have identi�ed four principles of an engaging patient experience »
Social influence and the behaviour of others closest to us primarily drives future behaviour
The most powerful influence on behaviour is un-conscious and emotional
The holistic customer experience, ‘beyond the pill’ drives brand relationships
Different conversations engage customers at different stages of the journey
Social »
Emotion »
Brands »
Engage »
9
Explore ››
PatientPulse: A framework for planning and evaluating the patient experience »
PatientPulse helps us understand the patient experience at each step along the journey.
It helps identify where the battle is being won or lost for different types of journeys and identifies the moments of truth and the experiences that detract from or reinforce disease and brand engagement.
Overall, it helps identify opportunities to connect more powerfully with patients and optimise the experience.
Identifying when, where and how to connect with patients.
10
Before: Explore understanding of the disease and their needs »
The ‘Before’ stage is when patients start to understand the disease and feel the need and urgency to consult a physician.
At this time patients form impressions and build knowledge by searching for information on the disease and treatment options.
As the patient becomes more engaged with the disease, they become more consciously involved and deepen their understanding. As this develops their needs become more refined and specific.
Creating disease engagement to steer patients towards the right treatment.
EDUCATION
Explore ››
11
During: optimising patient-doctor interaction »
Helping shape treatment decisions.This stage is about optimising the patient-doctor interaction so that the right treatment is prescribed.
It succeeds when doctors (and other HCPs) ask the right questions to enable patients to express accurately the information about their clinical needs and emotional priorities.
This in turn creates a situation where patients buy into the selected treatment. They also know what to expect, feeling well equipped and motivated to take the medication.
Optimal interaction means patients buy into treatment.
11
12
Patient satisfaction depends on how the holistic treatment experience matches up to expectations established earlier in the journey.
The experience goes ‘beyond the pill’ to include support services that help patients stay on treatment and get the results they need.
A positive experience builds intention to adhere and avoids potential switching to a competitor treatment.
Building enduring brand relationships
After: Encouraging adherence and advocacy »
14
Real world approaches that get closer to patients »
We identify the social and environmental context in which decision making takes place, uncovering the relationship between thoughts, feelings and behaviours.
We do this by using ‘real world’ research approaches that:
Observe actual behaviours
Reveal unconscious triggers and barriers
Pinpoint key moments of truth
Explore patients’ experiences over time
These approaches help us identify the gap between what people say they do and what they do in reality.
Identifying ways to influence desired patient behaviours.
17
Explore ››
Real world research approaches to provide a full picture of the patient experience »
BehaviourPatient charts
Social media monitoring
LongitudinalYourWord online research
Patient diaries
In Context‘In the moment’ mobile research
Ethnography
SocialYourWord online research
Social media monitoring
Uncovering what patients ‘do’, ‘feel’, and ‘think’.
DisruptionMock consultations
Physician observed patient groups
UnconsciousImplicit Response Test
Emotional response modelling
Trade off
Biometrics
ExperimentationTrade off
Controlled experiments
20
Find out more »
If you would like to learn more about PatientPulse and how it relates to your business issues, then please get in touch:
Global Head of Health – Abigail Stuart a.stuart@hallandpartners.com
Managing Partner, US – Soumya Roy PhD s.roy@hallandpartners.com
Managing Partner, EU - Lee Gazey l.gazey@hallandpartners.com
Partner, New York – Scott Kressner s.kressner@hallandpartners.com
Partner, London - Hannah Mann h.mann@hallandpartners.com
18
Summary of bene�ts »
Inspires » Provides a framework for planning and evaluating the patient experience, ‘beyond the pill’
Integrated » Captures what patients ‘do’, ‘feel’, and ‘think’ at each stage of the journey
Insightful » Reveals contextual, social and environmental factors that subconsciously influence behaviour
Reveals » Utilises ‘real world’ approaches and techniques to reveal moments of truth
Informs » Provides advice on how to create disease and brand engagement